ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
93,961.29
1.40%
S&P 500
5,906.94
-1.07%
Dow Jones
42,573.73
-0.97%
US Dollar vs Yen
156.8245
-0.12%
Brent Oil
74.435
0.45%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Tango Therapeutics Inc (TNGX) 銘柄情報

Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

NASDAQ
3.10
-0.02
(-0.64%)
終了 12月31日 6:00AM
15分遅延
3.10
0.00
( 0.00% )
プレマーケット: 7:21PM
15分遅延

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
3.10
買値
3.11
売値
3.20
出来高
1
0.00 日の範囲 0.00
2.70 52 週間の範囲 13.005
時価総額
332.995M
前日終値
3.10
始値
-
時刻
1
@
3.1
最終取引時間
19:02:07
財務取引量
-
VWAP
-
平均取引量 (3 か月)
2,000,520
発行済株式数
107,417,818
配当利回り
-
PER
-3.27
1 株当たり利益 (EPS)
-0.95
歳入
36.53M
純利益
-101.74M

Tango Therapeutics Inc について

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.tangotx.com
本社
Wilmington, Delaware, USA
設立
-
Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker TNGX. The last closing price for Tango Therapeutics was US$3.10. Over the last year, Tango Therapeutics shares have traded in a share price range of US$ 2.70 to US$ 13.005.

Tango Therapeutics currently has 107,417,818 shares in issue. The market capitalisation of Tango Therapeutics is US$333 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -3.27.

TNGX 最新ニュース

その他のニュース

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

2024年12月3日
Business Wire

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

2024年11月27日
Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

2024年11月21日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年11月19日
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

2024年11月8日
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

2024年11月7日
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2024年11月6日
Edgar (US Regulatory)

Form 8-K - Current report

2024年11月6日
Edgar (US Regulatory)

Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

– Positive TNG462 clinical activity across multiple tumor types in the phase 1/2 clinical trial, program moving into full development with multiple combination studies – – Clinical collaboration...

2024年11月6日
Business Wire

Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program

– TNG462 demonstrated durable clinical activity across multiple tumor types, including non-small cell lung cancer (NSCLC) and pancreatic cancer, in ongoing phase 1/2 clinical trial, moving into...

2024年11月6日
Business Wire
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.17-5.198776758413.273.282.964783553.09890199CS
4-0.78-20.10309278353.883.982.714362503.09965902CS
12-4-56.3380281697.17.46462.720005203.96555953CS
26-5.46-63.7850467298.5612.0152.713884245.77602951CS
52-6.7-68.36734693889.813.0052.710332356.89267166CS
156-7.83-71.63769441910.9313.032.477205517.11100277CS
260-6.51-67.74193548399.6118.842.476602487.33796722CS

TNGX - Frequently Asked Questions (FAQ)

What is the current Tango Therapeutics share price?
The current share price of Tango Therapeutics is US$ 3.10
How many Tango Therapeutics shares are in issue?
Tango Therapeutics has 107,417,818 shares in issue
What is the market cap of Tango Therapeutics?
The market capitalisation of Tango Therapeutics is USD 333M
What is the 1 year trading range for Tango Therapeutics share price?
Tango Therapeutics has traded in the range of US$ 2.70 to US$ 13.005 during the past year
What is the PE ratio of Tango Therapeutics?
The price to earnings ratio of Tango Therapeutics is -3.27
What is the cash to sales ratio of Tango Therapeutics?
The cash to sales ratio of Tango Therapeutics is 9.12
What is the reporting currency for Tango Therapeutics?
Tango Therapeutics reports financial results in USD
What is the latest annual turnover for Tango Therapeutics?
The latest annual turnover of Tango Therapeutics is USD 36.53M
What is the latest annual profit for Tango Therapeutics?
The latest annual profit of Tango Therapeutics is USD -101.74M
What is the registered address of Tango Therapeutics?
The registered address for Tango Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Tango Therapeutics website address?
The website address for Tango Therapeutics is www.tangotx.com
Which industry sector does Tango Therapeutics operate in?
Tango Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
EYENEyenovia Inc
US$ 0.2424
(113.95%)
61.31M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.2216
(79.29%)
52.92M
APMAptorum Group Ltd
US$ 2.41
(77.86%)
1.86M
MULNMullen Automotive Inc
US$ 1.685
(53.18%)
3.9M
NXUNXU Inc
US$ 2.21
(47.33%)
14.45M
SGMOSangamo Therapeutics Inc
US$ 1.20
(-48.72%)
663.51k
WATTEnergous Corporation
US$ 1.80
(-32.08%)
1.72M
SMXSMX Security Matters Public Company
US$ 0.6228
(-24.05%)
2.49M
XOMAXOMA Royalty Corporation
US$ 20.11
(-22.92%)
6
MSTXTidal Trust II Defiance Daily Target 2x Long MSTR ETF
US$ 41.05
(-22.58%)
572.52k
EYENEyenovia Inc
US$ 0.2426
(114.12%)
61.32M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.22
(77.99%)
53.04M
SVMHSRIVARU Holding Ltd
US$ 0.0375
(12.28%)
41.62M
CRKNCrown Electrokinetics Corporation
US$ 0.1695
(22.21%)
21.54M
HAOHaoxi Health Technology Ltd
US$ 0.192
(44.36%)
17.44M

TNGX Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
TNGX
Tango Therapeutics
TG
F0NC
Finnvera
BIT
1VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有